RadNet (NASDAQ:RDNT) Receives Daily Media Impact Rating of 0.32
News coverage about RadNet (NASDAQ:RDNT) has been trending positive on Friday, Accern Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RadNet earned a news sentiment score of 0.32 on Accern’s scale. Accern also assigned press coverage about the medical research company an impact score of 47.7728687339878 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Here are some of the news stories that may have impacted Accern Sentiment’s rankings:
- The Cancer Research Collaboration and Breastlink New York Partner With Diabetes Prevention Program Provider Blue Mesa Health (finance.yahoo.com)
- Zacks Investment Research Upgrades RadNet (RDNT) to Hold (americanbankingnews.com)
- Michael N. Murdock Sells 38,333 Shares of RadNet Inc. (RDNT) Stock (americanbankingnews.com)
- Marvin S. Cadwell Sells 35,594 Shares of RadNet Inc. (RDNT) Stock (americanbankingnews.com)
- Expecting an Accelerated Move Toward Higher Radnet Stock Prices (profitconfidential.com)
Shares of RadNet (RDNT) opened at $12.75 on Friday. The stock has a market capitalization of $607.20, a PE ratio of 43.97, a P/E/G ratio of 2.73 and a beta of 0.69. The company has a debt-to-equity ratio of 7.88, a current ratio of 1.29 and a quick ratio of 1.29. RadNet has a 1 year low of $5.32 and a 1 year high of $13.40.
Several equities research analysts have weighed in on RDNT shares. Zacks Investment Research upgraded RadNet from a “hold” rating to a “buy” rating and set a $11.00 price target on the stock in a report on Thursday, January 4th. BidaskClub upgraded RadNet from a “sell” rating to a “hold” rating in a report on Saturday, January 6th. Jefferies Group set a $14.00 price objective on RadNet and gave the company a “buy” rating in a report on Thursday, March 8th. FIX assumed coverage on RadNet in a report on Wednesday. They issued a “strong-buy” rating and a $15.00 price objective on the stock. Finally, Raymond James Financial assumed coverage on RadNet in a report on Wednesday. They issued a “strong-buy” rating and a $15.00 price objective on the stock. One analyst has rated the stock with a hold rating, two have issued a buy rating and two have given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $13.75.
In other RadNet news, EVP Michael N. Murdock sold 38,333 shares of the stock in a transaction that occurred on Wednesday, March 14th. The stock was sold at an average price of $13.06, for a total transaction of $500,628.98. Following the completion of the sale, the executive vice president now directly owns 107,242 shares of the company’s stock, valued at approximately $1,400,580.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider John V. Crues sold 19,684 shares of the stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $10.01, for a total value of $197,036.84. Following the transaction, the insider now directly owns 544,097 shares of the company’s stock, valued at $5,446,410.97. The disclosure for this sale can be found here. Insiders have sold a total of 108,611 shares of company stock valued at $1,326,138 over the last ninety days. 9.36% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: “RadNet (NASDAQ:RDNT) Receives Daily Media Impact Rating of 0.32” was originally reported by Marea Informative and is owned by of Marea Informative. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.mareainformativa.com/2018/03/16/favorable-media-coverage-somewhat-unlikely-to-impact-radnet-rdnt-share-price-updated-updated-updated.html.
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.